PTGER4 and chronic obstructive pulmonary disease: We have shown that EP4 receptor KO mice have enhanced inflammation after innate, allergic and COPD-like conditions, and cytokine production from primary human alveolar macrophages is attenuated by an EP4 agonist in a cAMP/PKA-dependent manner.